腹膜癌病患者接受细胞减灭术与腹腔热灌注化疗后发病率、死亡率及生存率评估数据集

资源简介

腹膜癌病患者接受细胞减灭术与腹腔热灌注化疗后发病率、死亡率及生存率评估数据集

【数据集背景】

本数据集源站标题为《Assessing morbidity, mortality, and survival in patients with peritoneal carcinomatosis undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy》。配套论文《Assessing morbidity, mortality, and survival in patients with peritoneal carcinomatosis undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy》发表于 Revista do Colégio Brasileiro de Cirurgiões（2023），DOI：10.1590/0100-6991e-20233421-en。源站首次发布：2023-04-15。

【数据内容】

源站原始描述：ABSTRACT Peritoneal carcinomatosis (PC) indicates advanced stage cancer, which is generally associated with a poor outcome and a 6 to 12 months. Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is an option for treating patients with primary PC, such as mesothelioma, or secondary PC, such as colorectal cancer (CRC) or pseudomixoma. Until recently, such patients were deemed untreatable. Objective: The purpose of this study was to assess the results of CRS + HIPEC…

【数据结构与技术规格】

文件数 60 个，合计 8.18 MB。数据集 DOI：10.6084/m9.figshare.22638683.v1。

【主题与分类】

源站学科分类：Surgery。主题标签：Mortality、Survival、Peritoneal Diseases、Cytoreduction Surgical Procedures、Hyperthermic Intraperitoneal Chemotherapy。

【适用方向】

源站学科分类标注为 Surgery。

【获取与许可】

源站页面：https://scielo.figshare.com/articles/dataset/Assessing_morbidity_mortality_and_survival_in_patients_with_peritoneal_carcinomatosis_undergoing_cytoreductive_surgery_and_hyperthermic_intraperitoneal_chemotherapy/22638683

使用许可：CC BY 4.0（https://creativecommons.org/licenses/by/4.0/）。

规范引用：VALLEJO, JAIRO SEBASTIÁN ASTUDILLO; QUEIROZ, FABIO LOPES DE; LACERDA FILHO, ANTÔNIO; FRANÇA NETO, PAULO ROCHA; COSTA, BRENO XAIA MARTINS DA; PAIVA, RODRIGO ALMEIDA; et al. (2023). Assessing morbidity, mortality, and survival in patients with peritoneal carcinomatosis undergoing cytoreductive surgery…

【使用注意】

· 源站最后修改于 2023-05-31，引用时请注意版本时效。